GRACE CHIEN: Open Payments
NPI 1164262143 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 56 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $498 · 2025 $1,007
Food & beverage: $1,007
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $306 |
| AstraZeneca Pharmaceuticals LP | 9 | $212 |
| Lilly USA, LLC | 9 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Novo Nordisk Inc | 4 | $65 |
| Amgen Inc. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $32 |
| Dexcom, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $17 |
Products named: QULIPTA, MOUNJARO, BREZTRI, CAPLYTA, UBRELVY, AIRSUPRA, Rybelsus, OTEZLA.
Industry payments across AZ — which companies pay providers there.
